Companies · Other Health Care

Sonendo, Inc.

Laguna Hills · Other Health Care

Diligence memoA one-page analyst read on Sonendo, Inc. — recommendation, valuation, rhythm, risks.
$241.5M
Total raised · real
13
Rounds
0.1×
Latest step-up
Top 2%
Sector rank · raised
Series C
Latest stage · inferred · Wed Apr 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Sonendo, Inc. looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.15× the median modeled value of Series C Other Health Care companies in 2025–2027 (20 peers) — value vs value, same stage and era.
Active
  • Last raise 14 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Sonendo, Inc. is one of 5377 Other Health Care companies tracked from Laguna Hills. By capital raised it ranks among the largest (ahead of 99% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
15
Investors (latest)
2025-04-30
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BPre-Seed · 2008-11-21 Raised $500K (real) Modeled valuation $15M (est)Pre-Seed2008Pre-Seed · 2009-06-03 Raised $718K (real) Modeled valuation $22M (est)Pre-Seed2009Seed · 2010-03-12 Raised $2.1M (real) Modeled valuation $53M (est)Seed2010Seed · 2010-03-12 Raised $2.9M (real) Modeled valuation $73M (est)Seed2010Series A · 2010-03-12 Raised $5.9M (real) Modeled valuation $120M (est)Series A2010Series A · 2012-06-12 Raised $9.2M (real) Modeled valuation $186M (est)Series A2012Series B · 2013-05-28 Raised $18M (real) Modeled valuation $399M (est)Series B2013Series B · 2013-12-31 Raised $3.1M (real) Modeled valuation $68M (est)Series B2013Series B · 2014-08-20 Raised $35M (real) Modeled valuation $775M (est)Series B2014Series B · 2016-05-16 Raised $33M (real) Modeled valuation $737M (est)Series B2016Series B · 2016-12-23 Raised $4.0M (real) Modeled valuation $89M (est)Series B2016Series B · 2017-05-05 Raised $850K (real) Modeled valuation $19M (est)Series B2017Series B · 2018-11-15 Raised $25M (real) Modeled valuation $554M (est)Series B2018Series B · 2019-06-19 Raised $17M (real) Modeled valuation $377M (est)Series B2019Series C · 2019-12-10 Raised $85M (real) Modeled valuation $1.9B (est)Series C2019Series C · 2025-04-30 Raised $5.0M (real) Modeled valuation $33M (est)Series C2025Cumulative $247M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$500K · 2008
Pre-Seed extension$718K · 2009
Seed$2.1M · 2010
Seed extension$2.9M · 2010
Series A$5.9M · 2010
Series A extension$9.2M · 2012
Series B$18.0M · 2013
Series B extension$3.1M · 2013
Series B extension$35.0M · 2014
Series B extension$33.3M · 2016
Series B extension$4.0M · 2016
Series B extension$850K · 2017
Series B extension$25.0M · 2018
Series B extension$17.0M · 2019
Series C$84.7M · 2019
Series C extension$5.0M · 2025

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$33.0M
Base estimate est.
$18.2M
Conservative case
$44.8M
Upside case
$33.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $15.4M · 2008-11-212008Pre-Seed · modeled $22.1M · 2009-06-03Seed · modeled $52.8M · 2010-03-12Seed · modeled $72.7M · 2010-03-12Series A · modeled $119.7M · 2010-03-12Series A · modeled $185.9M · 2012-06-12Series B · modeled $398.8M · 2013-05-28Series B · modeled $68.5M · 2013-12-31Series B · modeled $775.4M · 2014-08-20Series B · modeled $737.0M · 2016-05-16Series B · modeled $88.6M · 2016-12-23Series B · modeled $18.8M · 2017-05-05Series B · modeled $553.9M · 2018-11-15Series B · modeled $376.6M · 2019-06-19Series C · modeled $1.9B · 2019-12-10Series C · modeled $33.0M · 2025-04-302025
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
1.2 yr
Elapsed time used
1.2 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
13 mo
Avg between rounds
$14.7M/yr
Capital velocity
17.6 yr
On record since
2008
First round
16
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 99× above median
This company$241.5M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.1× of median
This company$5.0M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 1.5× above median
This company$33.0M
Sector median$22.1M

Raised more than 99% of sector peers (real $). Modeled value above 60% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #19 of 20.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)RESTOR3D, Inc. · Series C Raised $239.2M · modeled $522.3M (est)ByHeart, Inc. · Series C Raised $378.4M · modeled $493.6M (est)SpyGlassPharma, Inc. · Series C Raised $134.8M · modeled $485.1M (est)VantAI Holdings, Inc. · Series C Raised $86.3M · modeled $475.6M (est)BioIntelliSense, Inc. · Series C Raised $140.0M · modeled $329.0M (est)ObjectiveHealth, Inc. · Series C Raised $68.0M · modeled $321.2M (est)VentureMed Group, Inc. · Series C Raised $59.8M · modeled $288.2M (est)Exo Imaging, Inc. · Series C Raised $169.6M · modeled $284.6M (est)InspireMD, Inc. · Series C Raised $117.2M · modeled $248.3M (est)Fonar, Llc · Series C Raised $51.2M · modeled $229.0M (est)MicroTransponder, Inc. · Series C Raised $117.7M · modeled $223.3M (est)Fourth Edge LLC · Series C Raised $119.7M · modeled $222.0M (est)Sonendo, Inc. (this company) Raised $241.5M · modeled $33.0M (est)Sonendo, Inc.
CompanyStageRaised · realValue · estvs peer med.
RESTOR3D, Inc.Series C$239.2M$522.3M2.31×
ByHeart, Inc.Series C$378.4M$493.6M2.18×
SpyGlassPharma, Inc.Series C$134.8M$485.1M2.14×
VantAI Holdings, Inc.Series C$86.3M$475.6M2.10×
BioIntelliSense, Inc.Series C$140.0M$329.0M1.45×
ObjectiveHealth, Inc.Series C$68.0M$321.2M1.42×
VentureMed Group, Inc.Series C$59.8M$288.2M1.27×
Exo Imaging, Inc.Series C$169.6M$284.6M1.26×
InspireMD, Inc.Series C$117.2M$248.3M1.10×
Fonar, LlcSeries C$51.2M$229.0M1.01×
MicroTransponder, Inc.Series C$117.7M$223.3M0.99×
Fourth Edge LLCSeries C$119.7M$222.0M0.98×
Sonendo, Inc. this companySeries C$241.5M$33.0M0.15×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$500K2008-11-21$2.8M$15.4M85%
Pre-Seed$718K2009-06-03$4.0M$22.1M85%
Seed$2.1M2010-03-12$10.7M$52.8M85%
Seed$2.9M2010-03-12$14.7M$72.7M85%
Series A$5.9M2010-03-12$27.0M$119.7M85%
Series A$9.2M2012-06-12$41.9M$185.9M85%
Series B$18.0M2013-05-28$100.0M$398.8M85%
Series B$3.1M2013-12-31$17.2M$68.5M85%
Series B$35.0M2014-08-20$194.4M$775.4M85%
Series B$33.3M2016-05-16$184.8M$737.0M85%
Series B$4.0M2016-12-23$22.2M$88.6M90%
Series B$850K2017-05-05$4.7M$18.8M90%
Series B$25.0M2018-11-15$138.9M$553.9M90%
Series B$17.0M2019-06-19$94.4M$376.6M90%
Series C$84.7M2019-12-10$564.7M$1.9B90%
Series C$5.0M2025-04-30$33.3M$33.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$500K2008-11-21
    • First recorded raise — entered as Pre-Seed.
  2. Pre-Seed$718K2009-06-03
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 1.4× larger than the prior — scaling up.
    • 7 investors on this round.
  3. Seed$2.1M2010-03-12
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round 3.0× larger than the prior — scaling up.
    • 8 investors on this round.
  4. Seed$2.9M2010-03-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× larger than the prior — scaling up.
    • 8 investors on this round.
  5. Series A$5.9M2010-03-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× larger than the prior — scaling up.
    • 8 investors on this round.
  6. Series A$9.2M2012-06-12
    • Raised again after 27 mo — slower than the ~14 mo sector norm.
    • Round 1.6× larger than the prior — scaling up.
    • 12 investors on this round.
  7. Series B$18.0M2013-05-28
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 2.0× larger than the prior — scaling up.
    • 11 investors on this round.
  8. Series B$3.1M2013-12-31
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 5.8× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 1 investor on this round.
  9. Series B$35.0M2014-08-20
    • Came back fast: 8 mo vs the ~14 mo sector norm.
    • Round 11.3× larger than the prior — scaling up.
    • 8 investors on this round.
  10. Series B$33.3M2016-05-16
    • Raised again after 21 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 12 investors on this round.
  11. Series B$4.0M2016-12-23
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 8.3× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  12. Series B$850K2017-05-05
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 4.7× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  13. Series B$25.0M2018-11-15
    • Raised 18 mo later, in step with the ~14 mo sector norm.
    • Round 29.4× larger than the prior — scaling up.
    • 10 investors on this round.
  14. Series B$17.0M2019-06-19
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 6 investors on this round.
  15. Series C$84.7M2019-12-10
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 5.0× larger than the prior — scaling up.
    • 19 investors on this round.
  16. Series C$5.0M2025-04-30
    • Raised again after 65 mo — slower than the ~14 mo sector norm.
    • Round 16.9× smaller than the prior — bridge or down round.
    • 15 investors on this round.
Intelligence
2026 ~Q2
Modeled next raise · ~13mo cadence
$5.0M
Modeled next size est.range $5.0M$8.0M
0.1×
Last step-up
$14.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Olav B. Bergheim12 other2008-11
Hugh B. Neuharth6 other2013-12
Morteza Gharib4 other2008-11
Anthony P. Bihl III1 other2025-04
Hugh A. Neuharth1 other2012-06
Alex R. Crisses2019-12
Bjarne B. Bergheim2010-03
Bjarne Bergheim2009-06
Brooks R. Andrews2019-12
Carolyn P. Beaver2025-04
Cory R. Eaves2019-12
Daniel B. Even2013-12
Daniel R. Even2013-05
David R. Caluori2018-11
Erik B. Amble2013-12
Erik R. Amble2012-06
Fan R. Yu2013-12
John B. Glenn2016-12
John Bostjancic2025-04
John McGaugh2025-04
Kevin R. Cousins2013-05
Michael B. Watts2018-11
Michael R. Zhao2016-05
Morteza B. Gharib2010-03
Registry & provenance

Sonendo, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1407973
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Greatbatch, Inc.Other Health CareSeries D+$247.2M$5.7Bnetwork1 shared operator · same sector
LoneStar Heart, Inc.Other Health CareSeries A$25.2M$84.4Mnetwork2 shared operators · same sector
Anaxiom CorpOther Health CareSeries A$9.5M$19.7Mnetwork2 shared operators · same sector
Arges Imaging Inc.Other Health CarePre-Seed$855K$26.4Mnetwork2 shared operators · same sector
Adagio Medical, Inc.HealthtechSeries C$81.6M$128.1Mnetwork2 shared operators · same stage
GLAUKOS CorpOther Health CareSeries B$76.0M$664.6Mnetwork1 shared operator · same sector
ArcherDX, Inc.Other Health CareSeries C$115.1M$35.6Msame sector · same stage
BioHorizons, Inc.Other Health CareSeries C$64.1M$34.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Independa, Inc.Other Health CareSeries A$28.3M87%
Sonorous NV, Inc.Other Health CareSeed$19.2M86%
Prolaio, Inc.Other Health CareSeries B$224.0M86%
SonerMed, LLCOther Health CareSeries D+$6.7B85%
Glyscend, Inc.Other Health CareSeries A$96.9M85%
Arrellio, Inc.Other Health CareSeed$10.0M85%
ConsejoSano, Inc.Other Health CareSeries B$335.7M85%
Jutiso, Inc.Other Health CareSeries A$25.2M84%
Frequently asked
How much funding has Sonendo, Inc. raised?
Sonendo, Inc. has raised approximately $241.5M in disclosed capital across 13 recorded financing rounds, aggregated from public filings.
What is Sonendo, Inc.'s estimated valuation?
Provath's modeled valuation for Sonendo, Inc. is approximately $33.0M (modeled range $18.2M–$44.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Sonendo, Inc. at?
Sonendo, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Wed Apr 30.
What does Sonendo, Inc. do and where is it based?
Sonendo, Inc. operates in the Other Health Care sector, based in Laguna Hills.
Explore related

See where Sonendo, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Sonendo, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.